🏛️ Verified NIH Record • Updated 2026-07-02

ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™ (NCT06608823)

A Study to Assess Safety and Effectiveness of the JenaValve Trilogy™ Transcatheter Heart Valve System Versus Surgical Valve Replacement in Patients With Aortic Regurgitation

🟢 Recruiting Observational / Diagnostic ⚙️ Medical Device Protocol Sponsor: JenaValve Technology, Inc.

🩺 Plain-English Summary (8th-Grade Level)

To demonstrate non-inferiority of the Trilogy Transcatheter Heart Valve (THV) System compared with surgical aortic valve replacement (SAVR) for treatment of subjects with clinically significant native aortic regurgitation (AR)

Who can join: Review the eligibility criteria below.

Location: CPMC Sutter Health — Burlingame, California

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (29 Sites)

Showing the first 25 of 29 sites.

  • CPMC Sutter Health — Burlingame, California
  • Scripps Health — La Jolla, California
  • Cedars-Sinai Medical Center — Los Angeles, California
  • Los Robles Medical Center — Thousand Oaks, California
  • MedStar Washington Hospital Center — Washington D.C., District of Columbia
  • BayCare Health — Clearwater, Florida
  • HCA North Florida — Gainesville, Florida
  • Emory University Hospital — Atlanta, Georgia
  • Piedmont Healthcare — Atlanta, Georgia
  • Heart Care Centers of IL / Hinsdale Hospital — Chicago, Illinois
  • Ascension St. Vincent Heart Center — Carmel, Indiana
  • Beth Israel Deaconess Medical Center — Boston, Massachusetts
  • University of Michigan — Ann Arbor, Michigan
  • Henry Ford Health — Detroit, Michigan
  • Minneapolis Heart Institute Foundation — Minneapolis, Minnesota
  • Washington University - Barnes Jewish Hospital — St Louis, Missouri
  • Robert Wood Johnson University Hospital — New Brunswick, New Jersey
  • Buffalo General Medical Center — Buffalo, New York
  • Columbia University Medical Center — New York, New York
  • The Christ Hospital — Cincinnati, Ohio
  • The Cleveland Clinic Foundation — Cleveland, Ohio
  • Ohio Health — Columbus, Ohio
  • Oregon Health & Science University (OHSU) — Portland, Oregon
  • Lankenau Institute for Medical Research — Philadelphia, Pennsylvania
  • Houston Methodist Research Institute — Houston, Texas

📞 Contact the Study Coordinator

Phone: (949) 767-2110

Email: pinto@jenavalve.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

💡 How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
🏛️ View Official NIH Record ↗